Tempest Therapeutics (TPST) Price to Sales (2015 - 2018)

Tempest Therapeutics has disclosed Price to Sales across 4 years of filings, most recently posting 475.54 for Q3 2018.

• In Q3 2018, Price to Sales fell 47.48% year-over-year to 475.54; the TTM figure through Sep 2018 stood at 88.96 (down 43.16% YoY), while the FY2017 annual figure was 169.55, up 103.01% from the prior year.
• Price to Sales came in at 475.54 for Q3 2018 at Tempest Therapeutics, up from 400.76 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 62590.06 in Q1 2015 to a low of 400.76 in Q2 2018.
• Average Price to Sales over 4 years is 6843.63, with a median of 980.31 recorded in 2016.
• Year-over-year, Price to Sales tumbled 97.16% in 2016 and rose 21.95% in 2017.
• Over 4 years, Price to Sales stood at 1698.8 in 2015, then sank by 73.47% to 450.71 in 2016, then climbed by 21.95% to 549.63 in 2017, then retreated by 13.48% to 475.54 in 2018.
• Per Business Quant data, the three most recent Price to Sales figures were 475.54 in Q3 2018, 400.76 in Q2 2018, and 432.87 in Q1 2018.